Today’s science news gives me chills. For the first time ever, researchers have directly visualized what may be Parkinson’s earliest trigger in human brain tissue — alpha-synuclein oligomers. They found that in Parkinson’s samples, these tiny protein clusters are larger, brighter, and more numerous, and even identified a subclass unique to the disease. This could reshape how we diagnose, track, and treat Parkinson’s in its earliest stages — before symptoms even begin to take hold. What question